Adamis Pharms Corp Drug Patent Portfolio
Adamis Pharms Corp owns 1 orange book drug protected by 1 US patent Given below is the list of Adamis Pharms Corp's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11141540 | Syringe devices | 20 Oct, 2036 | Active |
Latest Legal Activities on Adamis Pharms Corp's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Adamis Pharms Corp.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Oct, 2021 | US11141540 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Oct, 2021 | US11141540 |
|
Email Notification
Critical
| 23 Sep, 2021 | US11141540 |
|
Issue Notification Mailed
Critical
| 22 Sep, 2021 | US11141540 |
| Dispatch to FDC | 14 Sep, 2021 | US11141540 |
|
Application Is Considered Ready for Issue
Critical
| 14 Sep, 2021 | US11141540 |
|
Issue Fee Payment Received
Critical
| 10 Sep, 2021 | US11141540 |
|
Issue Fee Payment Verified
Critical
| 10 Sep, 2021 | US11141540 |
|
Electronic Review
Critical
| 11 Jun, 2021 | US11141540 |
|
Email Notification
Critical
| 11 Jun, 2021 | US11141540 |
|
Mail Notice of Allowance
Critical
| 11 Jun, 2021 | US11141540 |
|
Notice of Allowance Data Verification Completed
Critical
| 09 Jun, 2021 | US11141540 |
|
Case Docketed to Examiner in GAU
Critical
| 12 May, 2021 | US11141540 |
|
Case Docketed to Examiner in GAU
Critical
| 10 Nov, 2020 | US11141540 |
| Disposal for a RCE / CPA / R129 | 06 Nov, 2020 | US11141540 |
Adamis Pharms Corp's Family Patents
Adamis Pharms Corp drugs have patent protection in a total of 17 countries. It's US patent count contributes only to 18.2% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Adamis Pharms Corp Drug List
Given below is the complete list of Adamis Pharms Corp's drugs and the patents protecting them.
1. Symjepi
Symjepi is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11141540 | Syringe devices |
20 Oct, 2036
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Symjepi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List